Lands' End, Stage Stores, Tactical High Income Shares and WBI Large Cap Tactical Growth Shares highlighted as Zacks Bull and Bear of the Day
PR Newswire
- Dec 29 Mon 2014 06:03
-
Lands' End, Stage Stores, Tactical High Income Shares and WBI Large Cap Tactical Growth Shares highlighted as Zacks Bull and Bear of the Day
- Dec 29 Mon 2014 06:03
-
OTC Markets Group Welcomes Castle Mountain Mining to OTCQX®
- Dec 29 Mon 2014 06:02
-
Provectus’ Intralesional PV-10 Clinical Data Published in the Annals of Surgical Oncology
Provectus’ Intralesional PV-10 Clinical Data Published in the Annals of Surgical Oncology
Article Now Available as an Epub Ahead of Print
- Dec 29 Mon 2014 06:01
-
Early findings of Harvard, Northeastern research show organic's benefits
Early findings of Harvard, Northeastern research show organic's benefits The Organic Center trustees hear updates on health, soil projects
- Dec 29 Mon 2014 06:00
-
The Seleni Institute Announces New Clinical Director
- Dec 29 Mon 2014 05:59
-
New Cyber Security Offerings, Office Expansion, Financial Results, and Upcoming Events - Research Reports on Palo Alto Networks, Yelp, Mobileye, Western Digital and Activision Blizzard
New Cyber Security Offerings, Office Expansion, Financial Results, and Upcoming Events - Research Reports on Palo Alto Networks, Yelp, Mobileye, Western Digital and Activision Blizzard Editor Note: For more information about this release, please scroll to bottom
- Dec 29 Mon 2014 05:59
-
SEC targets Wyly relatives in effort to collect $300 million claim
The U.S. and Securities Exchange Commission on Tuesday added more than a dozen relatives of Texas businessmen Sam and Charles Wyly to a long-running securities fraud lawsuit against the brothers to bolster its efforts to collect some $300 million.
The amended complaint filed in New York federal court included the relatives as "relief defendants," which means they are not accused of wrongdoing but can be subject to civil claims.
The filing was expected, as the SEC and the relatives continue to dispute whether hundreds of millions of dollars held in offshore trusts should be subject to collection.
U.S. District Judge Shira Scheindlin has said she will order the Wyly brothers' assets frozen at the SEC's request, including money previously transferred from the trusts to various relatives, despite objections from the family members.
The relatives include Charles Wyly's widow, Caroline Wyly; Sam's wife, Cheryl Wyly; and Sam's son, Evan Wyly.
- Dec 29 Mon 2014 05:58
-
GLOBAL MARKETS-Bonds rally, stocks fall as global economy fears mount
Stocks took a pounding on Wednesday, although Wall Street managed to peddle back from its steepest lows, and safe-haven government debt prices rose after U.S. and Chinese inflation data fanned worries about a global slowdown.
- Dec 29 Mon 2014 05:57
-
Premune Names Carl K. Johnson Chief Medical Officer
NEW YORK, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Premune, a development stage biopharmaceutical company focused on developing novel treatments for allergies and autoimmune-related disorders in companion animals, today announced the appointment of Dr. Carl K. Johnson, D.V.M. as Chief Medical Officer. Johnson, who will be based in Premune's New York office and report directly to CEO Viktor Karlsson, will be responsible for leading Premune's global product development initiatives. Johnson is the most recent senior-level hire since the Company announced the establishment of its U.S. office on April 15, 2014.
"We are extremely pleased to have Dr. Johnson join the Premune team as a distinguished veterinary and biotechnology leader with substantive experience in pharmaceutical and veterinary product development. We believe his proven knowledge and leadership will be of great assistance as we work toward advancing our proprietary pipeline of animal health product candidates," said Premune CEO and co-founder, Viktor Karlsson. "We were quite impressed with Carl's breadth of expertise and his deep understanding of veterinary pharmaceutical development. His experience in successfully advancing early stage R&D programs through clinical development is very valuable to a company like ours. We believe that Carl's strong technical and leadership capabilities will be a great asset as we work to develop our product pipeline."
Johnson joins Premune with more than 25 years of experience in animal health. Most recently, he was Global Head of Project and Portfolio Management at Merial, a subsidiary of Sanofi Company, where his team developed new pharmaceutical and biological products including, NexGard, which is used for the treatment of fleas and ticks, and Broadline, a topical endectocide for cats. Johnson was also involved in the development of several vaccine line extensions for both dogs and cats. Prior to Merial, Johnson worked with Baxter Healthcare's animal research facility in a variety of senior-level research positions focused on compliance, preclinical safety and efficacy research and product development. Johnson also held senior roles at Intervet, Inc. and in the animal health divisions of Pfizer and Schering-Plough. Johnson earned a Masters of Arts degree in Geological Sciences from Harvard University and a Doctor of Veterinary Medicine degree from Cornell University.
- Dec 29 Mon 2014 05:56
-
Ball Aerospace Wins NASA Earth Science HAWC-OAWL Research and Development Contract
Ball Aerospace Wins NASA Earth Science HAWC-OAWL Research and Development Contract
PR Newswire
